Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical Holdings Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Xtant Medical Holdings stock has a target of 1.50, which predicts a 145.78% increase from the current stock price of 0.61.

Price Target: $1.50 (+145.78%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$1.50	$1.50	$1.50	$1.50
Change	+145.78%	+145.78%	+145.78%	+145.78%

Analyst Ratings

According to 1 stock analyst, the rating for Xtant Medical Holdings is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	2	2	2	2	1	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ryan Zimmerman BTIG	BTIG	Strong Buy Maintains $2 → $1.5	Strong Buy	Maintains	$2 → $1.5	+145.78%	Nov 11, 2025
Ryan Zimmerman BTIG	BTIG	Strong Buy Maintains $2 → $3	Strong Buy	Maintains	$2 → $3	+391.56%	May 16, 2024
Ryan Zimmerman BTIG	BTIG	Strong Buy Initiates $2	Strong Buy	Initiates	$2	+227.71%	Dec 5, 2023
Chase Knickerbocker Craig-Hallum	Craig-Hallum	Strong Buy Maintains $1 → $1.2	Strong Buy	Maintains	$1 → $1.2	+96.62%	Jul 11, 2023
Chase Knickerbocker Craig-Hallum	Craig-Hallum	Strong Buy Initiates $1	Strong Buy	Initiates	$1	+63.85%	Apr 26, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

135.97M

Increased by 15.95%

from 117.27M

Revenue Next Year

115.67M

Decreased by -14.93%

from 135.97M

EPS This Year

0.03

from -0.12

EPS Next Year

0.01

Decreased by -80.00%

from 0.03

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	53.34M	55.26M	57.97M	91.30M	117.27M	135.97M	115.67M
Revenue Growth	-17.54%	3.61%	4.90%	57.50%	28.44%	15.95%	-14.93%
EPS	-0.25	-0.06	-0.09	0.01	-0.12	0.03	0.01
EPS Growth	-	-	-	-	-	-	-80.00%
Forward PE	-	-	-	-	-	23.93	119.67
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	140.2M	131.4M
Avg	136.0M	115.7M
Low	130.4M	99.7M

Revenue Growth

Revenue Growth	2025	2026	2027
High	19.5%	-3.4%
Avg	15.9%	-14.9%
Low	11.2%	-26.7%

EPS Forecast

EPS	2025	2026	2027
High	0.03	0.01
Avg	0.03	0.01
Low	0.02	-

EPS Growth

EPS Growth	2025	2026	2027
High	-	-58.8%
Avg	-	-80.0%
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.